P.46Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, multi-center prospective study

Autor:	S. LoRusso, N. Johnson, M. McDermott, K. Eichinger, R. Butterfield, K. Higgs, L. Lewis, K. Mul, B. Van Engelen, S. Sacconi, V. Sansone, E. Carraro, P. Shieh, K. Wagner, L. Wang, J. Statland, R. Tawil, null the ReSolve Investigators
Rok vydání:	2019
Předmět:	Protocol (science) medicine.medical_specialty Neurology Drug development business.industry Pediatrics Perinatology and Child Health Medicine Medical physics Center (algebra and category theory) Neurology (clinical) business Prospective cohort study Genetics (clinical)
Zdroj:	Neuromuscular Disorders. 29:S54
ISSN:	0960-8966
DOI:	10.1016/j.nmd.2019.06.075
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::13f1d1027430d8887af393da41be9fe9 https://doi.org/10.1016/j.nmd.2019.06.075 Zobrazit plný text záznamu Full Text from ScienceDirect